Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Martek Expects Growth With Restructuring Plan, Including Layoffs

This article was originally published in The Tan Sheet

Executive Summary

Martek Biosciences continues to push its growth with a new restructuring plan that should make it leaner and meaner, according to an Oct. 26 release

You may also be interested in...



Martek trims Kentucky operations

Martek Biosciences reduces its Winchester, Ky., workforce by about 45 people, nearly half its staffing at the facility, to offset infant formula price reductions, streamline operations and improve use of manufacturing capacity. Some manufacturing and distribution will move to Martek's Kingstree, S.C., site from Winchester, which lost about 100 workers during a 2006 restructuring (1"The Tan Sheet" Oct. 30, 2006). Martek expects to incur a non-cash asset impairment charge from the restructuring of $30 million to $40 million in the second half of its fiscal 2010. The Columbia, Md., nutritional oils firm said June 30 it plans to continue operations in Winchester, but potentially may sell or lease part of the facility

Martek trims Kentucky operations

Martek Biosciences reduces its Winchester, Ky., workforce by about 45 people, nearly half its staffing at the facility, to offset infant formula price reductions, streamline operations and improve use of manufacturing capacity. Some manufacturing and distribution will move to Martek's Kingstree, S.C., site from Winchester, which lost about 100 workers during a 2006 restructuring (1"The Tan Sheet" Oct. 30, 2006). Martek expects to incur a non-cash asset impairment charge from the restructuring of $30 million to $40 million in the second half of its fiscal 2010. The Columbia, Md., nutritional oils firm said June 30 it plans to continue operations in Winchester, but potentially may sell or lease part of the facility

Martek trims Kentucky operations

Martek Biosciences reduces its Winchester, Ky., workforce by about 45 people, nearly half its staffing at the facility, to offset infant formula price reductions, streamline operations and improve use of manufacturing capacity. Some manufacturing and distribution will move to Martek's Kingstree, S.C., site from Winchester, which lost about 100 workers during a 2006 restructuring (1"The Tan Sheet" Oct. 30, 2006). Martek expects to incur a non-cash asset impairment charge from the restructuring of $30 million to $40 million in the second half of its fiscal 2010. The Columbia, Md., nutritional oils firm said June 30 it plans to continue operations in Winchester, but potentially may sell or lease part of the facility

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS099897

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel